Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 5.09% is 68% below its 5-year average of 16.08%, near the low end of its 5-year range (-2.96%–33.59%).
As of the fiscal period ended Sunday, June 28, 2026. 43.58% below its 12-month average of 9.02%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
5.09%
RETURN ON EQUITY (ROE) AVG TTM
9.02%
RETURN ON EQUITY (ROE) AVG 3Y
6.25%
RETURN ON EQUITY (ROE) AVG 5Y
16.08%
RETURN ON EQUITY (ROE) AVG 10Y
18.04%
RETURN ON EQUITY (ROE) AVG 15Y
17.58%
RETURN ON EQUITY (ROE) AVG 20Y
16.85%
CURRENT VS TTM AVG
-43.58%
CURRENT VS 3Y AVG
-18.58%
CURRENT VS 5Y AVG
-68.36%
CURRENT VS 10Y AVG
-71.80%
CURRENT VS 15Y AVG
-71.05%
CURRENT VS 20Y AVG
-69.79%
SECTOR MEDIAN · HEALTHCARE
13.25%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
-61.60%
vs the sector median at left
Pfizer Inc.
Market Cap
$158.39B
Return on Equity (ROE)
5.09%
TTM Avg
9.02%
3Y Avg
6.25%
5Y Avg
16.08%
Market Cap
$144.25B
Return on Equity (ROE)
7.61%
TTM Avg
7.38%
3Y Avg
9.51%
5Y Avg
10.24%
Market Cap
$182.06B
Return on Equity (ROE)
-27.39%
TTM Avg
19.98%
3Y Avg
21.60%
5Y Avg
19.44%
Market Cap
$134.24B
Return on Equity (ROE)
21.76%
TTM Avg
8.96%
3Y Avg
15.60%
5Y Avg
19.47%
Market Cap
$182.59B
Return on Equity (ROE)
10.61%
TTM Avg
20.32%
3Y Avg
18.59%
5Y Avg
17.97%
Market Cap
$132.14B
Return on Equity (ROE)
41.59%
TTM Avg
-8.30%
3Y Avg
7.76%
5Y Avg
4.45%
Market Cap
$123.70B
Return on Equity (ROE)
17.28%
TTM Avg
15.07%
3Y Avg
13.91%
5Y Avg
13.46%
Market Cap
$122.58B
Return on Equity (ROE)
6.16%
TTM Avg
4.23%
3Y Avg
6.35%
5Y Avg
7.74%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pfizer Inc. (PFE) | $158.39B | 5.09% | 9.02% | 6.25% | 16.08% |
| Danaher Corporation (DHR)vs › | $144.25B | 7.61% | 7.38% | 9.51% | 10.24% |
| Gilead Sciences, Inc. (GILD)vs › | $182.06B | -27.39% | 19.98% | 21.60% | 19.44% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.24B | 21.76% | 8.96% | 15.60% | 19.47% |
| Abbott Laboratories (ABT)vs › | $182.59B | 10.61% | 20.32% | 18.59% | 17.97% |
| Bristol-Myers Squibb Company (BMY)vs › | $132.14B | 41.59% | -8.30% | 7.76% | 4.45% |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | 17.28% | 15.07% | 13.91% | 13.46% |
| CVS Health Corp. (CVS)vs › | $122.58B | 6.16% | 4.23% | 6.35% | 7.74% |
| Medtronic plc (MDT)vs › | $118.26B | N/A | 9.71% | 8.51% | 8.44% |
| Novo Nordisk A/S (NVO)vs › | $200.54B | 53.50% | 61.58% | 67.05% | 123.42% |
ROE
5.1%
ROA
2.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-28 | 5.09% |
| 2026-03-29 | 8.31% |
| 2025-12-31 | 8.99% |
| 2025-09-28 | 10.58% |
| 2025-06-29 | 12.12% |
| 2024-12-31 | 9.09% |
| 2024-09-29 | 4.63% |
| 2024-06-30 | -2.96% |
| 2024-03-31 | -0.31% |
| 2023-12-31 | 2.40% |
| 2023-10-01 | 10.80% |
| 2023-07-02 | 21.71% |
| 2023-04-02 | 28.76% |
| 2022-12-31 | 32.79% |
| 2022-10-02 | 32.14% |
| 2022-07-03 | 33.59% |
| 2022-04-03 | 30.60% |
| 2021-12-31 | 28.79% |
| 2021-10-03 | 26.00% |
| 2021-07-04 | 18.55% |
| 2021-04-04 | 15.57% |
| 2020-12-31 | 14.48% |
| 2020-09-27 | 12.22% |
| 2020-06-28 | 22.05% |
| 2020-03-29 | 24.21% |
| 2019-12-31 | 25.77% |
| 2019-09-29 | 24.91% |
| 2019-06-30 | 21.23% |
| 2019-03-31 | 19.51% |
| 2018-12-31 | 17.59% |
| 2018-09-30 | 33.40% |
| 2018-07-01 | 32.31% |
| 2018-04-01 | 30.99% |
| 2017-12-31 | 29.88% |
| 2017-10-01 | 16.14% |
| 2017-07-02 | 14.20% |
| 2017-04-02 | 12.43% |
| 2016-12-31 | 12.06% |
| 2016-10-02 | 9.85% |
| 2016-07-03 | 11.22% |
| 2016-04-03 | 12.09% |
| 2015-12-31 | 10.75% |
| 2015-09-27 | 12.51% |
| 2015-06-28 | 13.30% |
| 2015-03-29 | 13.64% |
| 2014-12-31 | 12.81% |
| 2014-09-28 | 13.43% |
| 2014-06-29 | 13.57% |
| 2014-03-30 | 27.76% |
| 2013-12-31 | 28.84% |
| 2013-09-29 | 33.03% |
| 2013-06-30 | 33.57% |
| 2013-03-31 | 18.88% |
| 2012-12-31 | 17.93% |
| 2012-09-30 | 11.86% |
| 2012-07-01 | 12.85% |
| 2012-04-01 | 11.51% |
| 2011-12-31 | 12.18% |
| 2011-10-02 | 12.73% |
| 2011-07-03 | 9.71% |
| 2011-04-03 | 9.39% |
| 2010-12-31 | 9.40% |
| 2010-10-03 | 7.00% |
| 2010-07-04 | 9.42% |
| 2010-04-04 | 8.85% |
| 2009-12-31 | 9.59% |
| 2009-09-27 | 12.29% |
| 2009-06-28 | 11.95% |
| 2009-03-29 | 13.36% |
| 2008-12-31 | 14.08% |
| 2008-09-28 | 15.68% |
| 2008-06-29 | 13.58% |
| 2008-03-30 | 11.17% |
| 2007-12-31 | 12.52% |
| 2007-09-30 | 22.32% |
| 2007-07-01 | 25.65% |
| 2007-04-01 | 25.68% |
| 2006-12-31 | 27.09% |
| 2006-10-01 | 18.10% |
| 2006-07-02 | 15.83% |
| 2006-04-02 | 17.08% |
| 2005-12-31 | 12.31% |
| 2005-10-02 | 12.24% |
| 2005-07-03 | 15.19% |
| 2005-04-03 | 13.81% |
| 2004-12-31 | 16.63% |
| 2004-09-26 | 13.35% |
| 2004-06-27 | 12.03% |
| 2004-03-28 | 2.28% |
| 2003-12-31 | 5.98% |
| 2003-09-28 | 8.99% |
| 2003-06-29 | 8.94% |
